Integral BioSystems and Nacuity Pharmaceuticals Ink Collaboration and License Deal
Firms to Develop Sustained Release Ophthalmic Drug Treatments with Nacuity Proprietary Compounds and Integral’s NanoM™ Platform Ophthalmic Insert Technology BEDFORD, MASSACHUSETTS, USA, August 13, 2021 /EINPresswire.com/ -- Bedford-based drug delivery …